Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein.

Bajaj BG, Murakami M, Cai Q, Verma SC, Lan K, Robertson ES.

J Virol. 2008 Apr;82(8):4082-90. doi: 10.1128/JVI.02500-07. Epub 2008 Feb 6.

2.

Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.

Saha A, Murakami M, Kumar P, Bajaj B, Sims K, Robertson ES.

J Virol. 2009 May;83(9):4652-69. doi: 10.1128/JVI.02408-08. Epub 2009 Feb 25.

3.

Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.

Knight JS, Sharma N, Robertson ES.

Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18562-6. Epub 2005 Dec 13.

4.

Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.

Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES.

Virology. 2009 Jun 5;388(2):236-47. doi: 10.1016/j.virol.2009.03.027. Epub 2009 Apr 24.

5.

Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.

Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES.

PLoS Pathog. 2011 Feb 10;7(2):e1001275. doi: 10.1371/journal.ppat.1001275.

6.

Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.

Wang A, Welch R, Zhao B, Ta T, KeleĊŸ S, Johannsen E.

J Virol. 2015 Dec 30;90(6):2906-19. doi: 10.1128/JVI.02737-15.

8.

Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.

Cai Q, Guo Y, Xiao B, Banerjee S, Saha A, Lu J, Glisovic T, Robertson ES.

PLoS Pathog. 2011 Dec;7(12):e1002418. doi: 10.1371/journal.ppat.1002418. Epub 2011 Dec 8.

9.
10.

Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.

Pei Y, Singh RK, Shukla SK, Lang F, Zhang S, Robertson ES.

J Virol. 2018 Aug 29;92(18). pii: e00663-18. doi: 10.1128/JVI.00663-18. Print 2018 Sep 15.

PMID:
29997218
12.

Conserved cell cycle regulatory properties within the amino terminal domain of the Epstein-Barr virus nuclear antigen 3C.

Sharma N, Knight JS, Robertson ES.

Virology. 2006 Mar 15;346(2):379-84. Epub 2005 Dec 20.

13.

Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.

Jha HC, A J MP, Saha A, Banerjee S, Lu J, Robertson ES.

J Virol. 2014 Apr;88(7):3776-88. doi: 10.1128/JVI.03568-13. Epub 2014 Jan 15.

14.

EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.

Jha HC, Lu J, Saha A, Cai Q, Banerjee S, Prasad MA, Robertson ES.

J Virol. 2013 Nov;87(22):12121-38. doi: 10.1128/JVI.02379-13. Epub 2013 Aug 28.

15.

SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen.

Knight JS, Sharma N, Robertson ES.

Mol Cell Biol. 2005 Mar;25(5):1749-63.

16.

EBNA3C can modulate the activities of the transcription factor Necdin in association with metastasis suppressor protein Nm23-H1.

Kaul R, Murakami M, Lan K, Choudhuri T, Robertson ES.

J Virol. 2009 May;83(10):4871-83. doi: 10.1128/JVI.02286-08. Epub 2008 Dec 30.

17.

The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.

Banerjee S, Lu J, Cai Q, Saha A, Jha HC, Dzeng RK, Robertson ES.

PLoS Pathog. 2013;9(5):e1003314. doi: 10.1371/journal.ppat.1003314. Epub 2013 May 2.

19.

EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation.

Banerjee S, Lu J, Cai Q, Sun Z, Jha HC, Robertson ES.

PLoS Pathog. 2014 Aug 14;10(8):e1004304. doi: 10.1371/journal.ppat.1004304. eCollection 2014 Aug.

20.

Supplemental Content

Support Center